This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.
Ages 2 - 8
Autism spectrum disorder diagnosis
CARS-2 score of 30 - 45
CARS scores less than 30 or over 45.
Taking psychotropic medications.
Having skin lesions on scalp
Having history of seizures
State University of New York - Upstate Medical University
Lead sponsor
JelikaLite LLC
Collaborator
Mt. Sinai School of Medicine, New York, New York
Collaborator
MetroEHS
Collaborator